Association of insulin-like growth factor 1 receptor and estrogen receptor with pathological complete response to neoadjuvant chemotherapy in HER2-negative breast cancer.

CONCLUSION: ER-negative patients were more sensitive to neoadjuvant chemotherapy, and the pCR rate was significantly higher in ER-negative than in ER-positive patients in the high-IGF1R subgroup. PMID: 30617938 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30617938?dopt=Abstract

Source: Breast Cancer - January 8, 2019 Category: Cancer & Oncology Authors: Liu L, Hu Y, Zhang S, Li X, Zhang J Tags: Breast Cancer Source Type: research